Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Target GroupCBDY FCF Margin % is -15.24% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 960 Drug Manufacturers companies, Target Group ranks worse than 76.15% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Target Group's Free Cash Flow for the
three
months ended in Mar. 2026 was $-0.13 Mil. Target Group's Revenue for the
three
months ended in Mar. 2026 was $0.88 Mil. Therefore, Target Group's FCF Margin % for the quarter that ended in Mar. 2026 was -15.24%.
The historical data trend for Target Group's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Target Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Target Group FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Target Group's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Target Group's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Target Group (CBDY) has a FCF Margin % of -15.24% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Target Group and its competitors. According to the industry distribution chart, Target Group ranks #731 out of 960 companies in the Drug Manufacturers industry, placing it in the top 76.1%.
Is Target Group's FCF Margin % too high?
Target Group's current FCF Margin % is -15.24%. Based on the distribution chart, Target Group ranks #731 out of 960 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Target Group's FCF Margin % compare to IMCC and GRPS?
According to the Drug Manufacturers industry distribution chart, Target Group ranks #731 out of 960 companies for FCF Margin %. This places Target Group in the lower half of its industry. The industry median FCF Margin % is 2.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.39, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Target Group and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Target Group's current FCF Margin % is -15.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Target Group stock overvalued right now?
Target Group (CBDY) has a current FCF Margin % of -15.24%. The current FCF Margin % is -15.24%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Target Group (CBDY), the current FCF Margin % is -15.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Target Group Inc is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada. The company generates revenue from the sale of Wisp vaporizer and Wisp pod units. Its product manufacturing includes Cannabis flower pods for vaporizer use, , extract pods for vaporizer use, Cannabis pre-rolls, K-Cup infused coffee and tea pods, Infused cannabis beverages, etc. Geographically, the company operates in Canada, Israel, Germany, Australia, UK and Poland region generating key revenue from Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBDY has been successfully added to your 
